Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center

被引：0
|
作者：
M R Abern
M R Bassett
M Tsivian
L L Bañez
T J Polascik
M N Ferrandino
C N Robertson
S J Freedland
J W Moul
机构：
[1] Duke Cancer Institute,Division of Urology, Department of Surgery and the Duke Prostate Center
[2] Duke University Medical Center,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2013年 / 16卷
关键词：
prostate adenocarcinoma; active surveillance; race;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：85 / 90
页数：5
相关论文
共 50 条
  • [31] THE QUALITY OF ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER
    Levy, Mya E.
    Meyers, Stephanie
    Wood, David P.
    Montie, James E.
    Miller, David C.
    Wei, John T.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 179 - 179
  • [32] Active Surveillance for Low-risk Prostate Cancer: Developments to Date
    Bangma, Chris H.
    Valdagni, Riccardo
    Carroll, Peter R.
    van Poppel, Hein
    Klotz, Laurence
    Hugosson, Jonas
    EUROPEAN UROLOGY, 2015, 67 (04) : 646 - 648
  • [33] Impact of Race on Selecting Appropriate Patients for Active Surveillance With Seemingly Low-risk Prostate Cancer
    Pietzak, Eugene J.
    Van Arsdalen, Keith
    Patel, Kinnari
    Malkowicz, S. Bruce
    Wein, Alan J.
    Guzzo, Thomas J.
    UROLOGY, 2015, 85 (02) : 436 - 441
  • [34] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [35] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [36] Active Surveillance for Low-Risk Prostate Cancer: Experience at a Department of Veterans' Affairs Medical Center
    Kava, Bruce R.
    Volsky, Alexander
    Iremashvili, Viacheslav
    JOURNAL OF MENS HEALTH, 2014, 11 (01) : A12 - A12
  • [37] Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
    Cimino, Sebastiano
    Privitera, Salvatore
    Favilla, Vincenzo
    Cantiello, Francesco
    Manno, Stefano
    Cicione, Antonio
    Damiano, Rocco
    Russo, Giorgio Ivan
    Morgia, Giuseppe
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (07) : 958 - 963
  • [38] Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer
    Srivastava, Arnav
    Kaufman, Samuel R.
    Shay, Addison
    Oerline, Mary
    Liu, Xiu
    Van Til, Monica
    Linsell, Susan
    Labardee, Corinne
    Dall, Christopher
    Faraj, Kassem S.
    Maganty, Avinash
    Borza, Tudor
    Ginsburg, Kevin
    Hollenbeck, Brent K.
    Shahinian, Vahakn B.
    JAMA NETWORK OPEN, 2025, 8 (01)
  • [39] Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer
    Haffty, Bruce G.
    Lawton, Colleen A. F.
    Sandler, Howard
    JAMA ONCOLOGY, 2015, 1 (05) : 688 - 689
  • [40] Evolving indications for active surveillance in low-risk localized prostate cancer
    Carroll, PR
    Cooperberg, MR
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (09) : 7 - 13
12345